Pediatric Study Requirements For Cancer Have FDA Support, But Pose Industry Challenges

Biosimilars could face new requirements if RACE for Children Act expands PREA to molecularly targeted cancer drugs approved for adult indications; other stakeholders also worry about general feasibility.

ChildHandWithIV_1200x675

The next Prescription Drug User Fee Act reauthorization could provide a platform for legislation expanding the Pediatric Research Equity Act's reach into childhood cancer.

The Research to Accelerate Cures and Equity for Children Act, also known as the RACE for Children Act,...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet